Post by Forus Health

Behind every image is an opportunity for early detection. Retinoblastoma is a rare, aggressive eye cancer starting in the retina, primarily affecting children under 4 years old. In case of early diagnosis (subjective to location), the cure rate is over 90-95% when confined to the eye. In conditions like retinoblastoma, timely diagnosis matters. With the 3nethra neo, high-quality retinal imaging enables clearer, faster identification of ocular conditions. Its wide-field imaging supports comprehensive documentation, even in deeper regions of the eye. When advanced technology meets AI, early detection becomes more accessible. #retinoblastoma #eyescreeningawarness #AInnovation #Retinalimaging #Earlydetection